Literature DB >> 22795107

Osteogenesis imperfecta type IV: prenatal molecular diagnosis and genetic counseling in a pregnancy carried to full term with favorable outcome.

Chih-Ping Chen1, Shuan-Pei Lin, Yi-Ning Su, Schu-Rern Chern, Ming-Huei Lin, Jun-Wei Su, Wayseen Wang.   

Abstract

OBJECTIVE: To present molecular diagnosis and genetic counseling for osteogenesis imperfecta (OI) type IV in a pregnancy carried to term with favorable outcome. CASE REPORT: A 34-year-old, primigravid woman was referred for genetic counseling in the second trimester because of advanced maternal age and a positive family history of OI type IV. Her husband had a weight of 40 kg and a height of 145 cm. Her husband had normal sclerae, moderate short stature and osteopenia, and had sustained multiple fractures with minimal trauma since childhood. The husband and his relatives including his mother, aunt, uncle, sister and nephew had suffered from OI type IV. Molecular analysis of the affected individuals in the family revealed a G to T change at position c.2197 (c.2197G>T, GGT>TGT) of the exon 37 in the COL1A2 gene leading to a change of glycine at codon 733 to cysteine (G733C). Cytogenetic analysis of cultured amniocytes revealed a karyotype of 46,XY. Molecular analysis of uncultured amniocytes revealed a missense mutation of G733C in COL1A2. Level II ultrasound at 23 weeks of gestation revealed significant shortness of the limbs. Small stature for gestation age was obvious in the third trimester. At 37 weeks of gestation, a fetal ultrasound showed curvature of the femurs. A cesarean section was performed at 38 weeks of gestation, and a male baby was delivered uneventfully. The baby had normal sclerae, a body weight of 2190 g (< 5(th) centile) and a body length of 46 cm (< 5(th) centile). X-rays showed thin clavicles and short curved femurs but no bony fractures. No fractures were noted at the age of 1 month.
CONCLUSION: The present case adds to previous examples of favorable outcome in pregnancies with non-lethal forms of OI.
Copyright © 2012. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795107     DOI: 10.1016/j.tjog.2012.04.019

Source DB:  PubMed          Journal:  Taiwan J Obstet Gynecol        ISSN: 1028-4559            Impact factor:   1.705


  3 in total

1.  Clinical application of antenatal genetic diagnosis of osteogenesis imperfecta type IV.

Authors:  Jing Yuan; Song Li; YeYe Xu; Lin Cong
Journal:  Med Sci Monit       Date:  2015-04-02

2.  Clinical aspects, imaging features, and considerations on bisphosphonate-related osteonecrosis risk in a pediatric patient with osteogenesis imperfecta.

Authors:  Fábio Wildson Gurgel Costa; Filipe Nobre Chaves; Alexandre Simões Nogueira; Francisco Samuel Rodrigues Carvalho; Karuza Maria Alves Pereira; Lúcio Mitsuo Kurita; Rodrigo Rodrigues Rodrigues; Cristiane Sá Roriz Fonteles
Journal:  Case Rep Dent       Date:  2014-08-26

3.  Osteogenesis imperfecta Type IV: a newly identified variant at position c.560 (G > T; p.Gly187Val) in the COL1A2 gene.

Authors:  Akin Usta; Dilay Karademir; Eylem Sen; Selcuk Yazici; Ertan Adali; Erkan Erdem; Meric Karacan
Journal:  Pan Afr Med J       Date:  2017-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.